Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations

被引：25

作者：

Diefenbach, Catherine S. ^{[1
]}

Connors, Joseph M. ^{[2
]}

Friedberg, Jonathan W. ^{[3
,4
]}

Leonard, John P. ^{[5
]}

Kahl, Brad S. ^{[6
]}

Little, Richard F. ^{[7
]}

Baizer, Lawrence ^{[8
]}

Evens, Andrew M. ^{[9
,10
]}

Hoppe, Richard T. ^{[11
]}

Kelly, Kara M. ^{[12
]}

Persky, Daniel O. ^{[13
]}

Younes, Anas ^{[14
]}

Kostakaglu, Lale ^{[15
]}

Bartlett, Nancy L. ^{[6
]}

机构：

[1] NYU, Perlmutter Canc Ctr, 240 East 38th St,19th Floor, New York, NY 10016 USA

[2] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada

[3] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA

[4] Univ Rochester, Med Ctr, Div Hematol Oncol, Rochester, NY 14642 USA

[5] Weil Cornell Univ, Dept Med, New York, NY USA

[6] Washington Univ, Dept Med, Div Oncol, St Louis, MO USA

[7] Tufts Univ, Sch Med, Div Canc Treatment & Diag, Boston, MA 02111 USA

[8] Tufts Univ, Sch Med, Coordinating Ctr Clin Trials, Boston, MA 02111 USA

[9] Tufts Univ, Sch Med, Tufts Canc Ctr, Boston, MA 02111 USA

[10] Tufts Univ, Sch Med, Div Hematol Oncol, Boston, MA 02111 USA

[11] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA

[12] Columbia Univ, Div Pediat Hematol Oncol Stem Cell Transplant, Med Ctr, New York, NY USA

[13] Univ Arizona, Ctr Canc, Dept Med, Tucson, AZ USA

[14] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA

[15] Mt Sinai Hosp, Dept Radiol, New York, NY 10029 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2017年 / 109卷 / 04期

基金：

美国国家卫生研究院;

关键词：

REED-STERNBERG CELLS; EPSTEIN-BARR-VIRUS; INTERNATIONAL PROGNOSTIC SCORE; INVOLVED-FIELD RADIOTHERAPY; TUMOR-ASSOCIATED MACROPHAGES; COOPERATIVE-ONCOLOGY-GROUP; RADIATION-THERAPY; BRENTUXIMAB VEDOTIN; PHASE-II; DEFINED SUBGROUPS;

D O I：

10.1093/jnci/djw249

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The National Clinical Trials Network lymphoid malignancies Clinical Trials Planning Meeting (CTPM) occurred in November of 2014. The scope of the CTPM was to prioritize across the lymphoid tumors clinically significant questions and to foster strategies leading to biologically informed and potentially practice changing clinical trials. This review from the Hodgkin lymphoma (HL) subcommittee of the CTPM discusses the ongoing clinical challenges in HL, outlines the current standard of care for HL patients from early to advanced stage, and surveys the current science with respect to biomarkers and the landscape of ongoing clinical trials. Finally, we suggest areas of unmet need in HL and elucidate promising therapeutic strategies to guide future HL clinical trials planning across the NCTN.

引用

页数：12

共 50 条

[1] Current status of prognostication in classical Hodgkin lymphoma
Venkataraman, Girish
Mirza, M. Kamran
Eichenauer, Dennis A.
Diehl, Volker
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (03) : 287 - 299
[2] Recommendations for Clinical Trial Development in Follicular Lymphoma
Maddocks, Kami
Barr, Paul M.
Cheson, Bruce D.
Little, Richard F.
Baizer, Lawrence
Kahl, Brad S.
Leonard, John P.
Fowler, Nathan
Gordon, Leo I.
Link, Brian K.
Friedberg, Jonathan W.
Ansell, Stephen M.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (03):
[3] Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects
Ng, Andrea K.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 488 - 494
[4] Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects
Ng, Andrea K.
BLOOD, 2014, 124 (23) : 3373 - 3379
[5] CLINICAL-TRIALS - CURRENT STATUS AND RECOMMENDATIONS
CLAGETT, GP
JOURNAL OF VASCULAR SURGERY, 1991, 13 (05) : 761 - 763
[6] Recommendations for Clinical Trial Development in Mantle Cell Lymphoma
Spurgeon, Stephen E.
Till, Brian G.
Martin, Peter
Goy, Andre H.
Dreyling, Martin P.
Gopal, Ajay K.
LeBlanc, Michael
Leonard, John P.
Friedberg, Jonathan W.
Baizer, Lawrence
Little, Richard F.
Kahl, Brad S.
Smith, Mitchell R.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
[7] Current status of therapeutic vaccines for non-Hodgkin's lymphoma
Hurvitz, SA
Timmerman, JM
CURRENT OPINION IN ONCOLOGY, 2005, 17 (05) : 432 - 440
[8] Radioimmunotherapy for Non-Hodgkin Lymphoma : Historical Perspective and Current Status
Emmanouilides, Christos
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2007, 47 (02) : 43 - 60
[9] Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma
van Besien, Koen
CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 681 - 691
[10] Treatment of early stage Hodgkin lymphoma. Discussion of current trials and treatment recommendations
Sasse, S.
Broeckelmann, P. J.
Baues, C.
Eich, H. T.
Engert, A.
ONKOLOGE, 2018, 24 (04): : 303 - 314

← 1 2 3 4 5 →